These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9838195)

  • 1. Effects of D2 dopamine receptor agonist and antagonist on brain activity in the rat assessed by functional magnetic resonance imaging.
    Hagino H; Tabuchi E; Kurachi M; Saitoh O; Sun Y; Kondoh T; Ono T; Torii K
    Brain Res; 1998 Dec; 813(2):367-73. PubMed ID: 9838195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of brain activity between dopamine D2 receptor-knockout and wild mice in response to dopamine agonist and antagonist assessed by fMRI.
    Kuriwaki J; Nishijo H; Kondoh T; Uwano T; Torii K; Katsuki M; Ono T
    Neurosignals; 2004; 13(5):227-40. PubMed ID: 15305090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 receptor effects on GABA(A) receptor expression may modify melanotrope peptide release.
    Sands SA; de Blas AL; Chronwall BM
    Peptides; 1998; 19(2):397-401. PubMed ID: 9493875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine suppresses stimulus-induced field potentials in layer III of rat medial entorhinal cortex.
    Stenkamp K; Heinemann U; Schmitz D
    Neurosci Lett; 1998 Oct; 255(2):119-21. PubMed ID: 9835229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of D2 dopamine receptor antagonists on Fos protein expression in the striatal complex and entorhinal cortex of the nonhuman primate.
    Deutch AY; Lewis DA; Whitehead RE; Elsworth JD; Iadarola MJ; Redmond DE; Roth RH
    Synapse; 1996 Jul; 23(3):182-91. PubMed ID: 8807746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
    Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
    Sumiyoshi T; Ichikawa J; Meltzer HY
    Neuropsychopharmacology; 1997 Mar; 16(3):183-90. PubMed ID: 9138434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex.
    Izquierdo-Claros RM; del Boyano-Adánez M; Arilla-Ferreiro E
    J Neurosci Res; 2000 Oct; 62(1):91-8. PubMed ID: 11002291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dopaminergic modulation on electrophysiological brain response to affective stimuli.
    Franken IH; Nijs I; Pepplinkhuizen L
    Psychopharmacology (Berl); 2008 Jan; 195(4):537-46. PubMed ID: 17891382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain.
    Chong VZ; Skoblenick K; Morin F; Xu Y; Mishra RK
    Neuroscience; 2006; 138(2):587-99. PubMed ID: 16413126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor.
    Morisset S; Pilon C; Tardivel-Lacombe J; Weinstein D; Rostene W; Betancur C; Sokoloff P; Schwartz JC; Arrang JM
    J Pharmacol Exp Ther; 2002 Feb; 300(2):621-8. PubMed ID: 11805225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of dopaminergic D2 stimulation and blockade on smoking behavior.
    Caskey NH; Jarvik ME; Wirshing WC
    Exp Clin Psychopharmacol; 1999 Feb; 7(1):72-8. PubMed ID: 10036612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic Modulation of Lateral Amygdala Neuronal Activity: Differential D1 and D2 Receptor Effects on Thalamic and Cortical Afferent Inputs.
    Chang CH; Grace AA
    Int J Neuropsychopharmacol; 2015 Feb; 18(8):. PubMed ID: 25716776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D2 receptor stimulation alters G-protein expression in rat pituitary intermediate lobe melanotropes.
    Sands SA; Dickerson DS; Morris SJ; Chronwall BM
    Endocrine; 1997 Jun; 6(3):325-33. PubMed ID: 9368690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride.
    Kessler RM; Whetsell WO; Ansari MS; Votaw JR; de Paulis T; Clanton JA; Schmidt DE; Mason NS; Manning RG
    Brain Res; 1993 Apr; 609(1-2):237-43. PubMed ID: 8099521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.
    Bowery BJ; Razzaque Z; Emms F; Patel S; Freedman S; Bristow L; Kulagowski J; Seabrook GR
    Br J Pharmacol; 1996 Dec; 119(7):1491-7. PubMed ID: 8968560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol.
    Mo YQ; Jin XL; Chen YT; Jin GZ; Shi WX
    Neuropsychopharmacology; 2005 Feb; 30(2):261-7. PubMed ID: 15578005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.